Startseite>>(R)-(+)-Eicosapentaenyl-1'-Hydroxy-2'-Propylamide

(R)-(+)-Eicosapentaenyl-1'-Hydroxy-2'-Propylamide

Katalog-Nr.GC41710

N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.

Products are for research use only. Not for human use. We do not sell to patients.

(R)-(+)-Eicosapentaenyl-1'-Hydroxy-2'-Propylamide Chemische Struktur

Größe Preis Lagerbestand
1mg
111,00 $
Please Inquire
5mg
502,00 $
Please Inquire
10mg
891,00 $
Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. Eicosapentaenoyl ethanolamide (EPEA) has potential signaling roles in aging, cancer, inflammation, and neurological development. At least some of EPEA's effects are mediated through cannabinoid (CB) receptors, while some NAEs also act as vanilloid receptor agonists. R-(+)-Eicosapentaenyl-1'-hydroxy-2'-propylamide is a homolog of EPEA, characterized by the addition of an (R)-α-methyl group at the methylene carbon adjacent to the amide nitrogen. A similar modification of arachidonoyl ethanolamide to produce R-1 methanandamide imparts higher affinity for the CB receptor as well as improved metabolic stability. The physiological actions of this compound have not been evaluated.

Bewertungen

Review for (R)-(+)-Eicosapentaenyl-1'-Hydroxy-2'-Propylamide

Average Rating: 5 ★★★★★ (Based on Reviews and 18 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (R)-(+)-Eicosapentaenyl-1'-Hydroxy-2'-Propylamide

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.